|
1
|
Biray Avci C, Goker Bagca B, Nikanfar M,
Takanlou LS, Takanlou MS and Nourazarian A: Tumor microenvironment
and cancer metastasis: Molecular mechanisms and therapeutic
implications. Front Pharmacol. 15:14428882024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li Y, Liu F, Cai Q, Deng L, Ouyang Q,
Zhang XH and Zheng J: Invasion and metastasis in cancer: Molecular
insights and therapeutic targets. Sig Transduct Target Ther.
10:572025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miyazono K, Katsuno Y, Koinuma D, Ehata S
and Morikawa M: Intracellular and extracellular TGF-β signaling in
cancer: Some recent topics. Front Med. 12:387–411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xie Y, Wang X, Wang W, Pu N and Liu L:
Epithelial-mesenchymal transition orchestrates tumor
microenvironment: Current perceptions and challenges. J Transl Med.
23:3862025. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Robinson DR, Wu YM, Lonigro RJ, Vats P,
Cobain E, Everett J, Cao X, Rabban E, Kumar-Sinha C, Raymond V, et
al: Integrative clinical genomics of metastatic cancer. Nature.
548:297–303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
7
|
Hernández-Morales A, González-López BS,
Scougall-Vilchis RJ, Bermeo-Escalona JR, Velázquez-Enríquez U,
Islas-Zarazúa R, Márquez-Rodríguez S, Sosa-Velasco TA, Medina-Solís
CE and Maupomé G: Lip and oral cavity cancer incidence and
mortality rates associated with smoking and chewing tobacco use and
the human development index in 172 countries worldwide: An
ecological study 2019–2020. Healthcare (Basel). 11:10632023.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kinoshita N, Tomioka H, Oikawa Y, Fukawa
Y, Ikeda T and Harada H: A case of sclerosing odontogenic carcinoma
of the mandible with a review of the literature. J Oral Sci.
65:281–283. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tranby EP, Heaton LJ, Tomar SL, Kelly AL,
Fager GL, Backley M and Frantsve-Hawley J: Oral cancer prevalence,
mortality, and costs in Medicaid and commercial insurance claims
data. Cancer Epidemiol Biomarkers Prev. 31:1849–1857. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miranda-Filho A and Bray F: Global
patterns and trends in cancers of the lip, tongue and mouth. Oral
Oncol. 102:1045512020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S,
Nice EC, Tang J and Huang C: Oral squamous cell carcinomas: State
of the field and emerging directions. Int J Oral Sci. 15:442023.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Katsuno Y and Derynck R: Epithelial
plasticity, epithelial-mesenchymal transition, and the TGF-β
family. Dev Cell. 56:726–746. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ling H, Xiao S, Lei Y, Zhou Y, Tan J, Chen
X, Ma D, Liang C, Liu Q, Liu W and Zeng T: The advancement of
ubiquitination regulation in apoptosis, ferroptosis, autophagy,
drug resistance and treatment of cancer. Arch Biochem Biophys.
771:1104972025. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Gao G, Wei X, Zhang Y and Yu J:
UBE2T promotes temozolomide resistance of glioblastoma through
regulating the Wnt/β-catenin signaling pathway. Drug Des Devel
Ther. 17:1357–1369. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng J, Dai X, Zhang T, Hu G, Cao H, Guo
X, Fan H, Chen J, Tang W and Yang F: Copper as the driver of the
lncRNA-TCONS-6251/miR-novel-100/TC2N axis: Unraveling ferroptosis
in duck kidney. Int J Biol Macromol. 282((Pt 2)): 1367972024.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Dai X, Xing C, Zhang Y, Cao H, Hu
G, Guo X, Gao X, Liu P and Yang F: Cooperative application of
transcriptomics and ceRNA hypothesis: lncRNA-00742/miR-116 targets
CD74 to mediate vanadium-induced mitochondrial apoptosis in duck
liver. J Hazard Mater. 480:1359042024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y,
Lu B, Fan Y, Liu Z, Chen X, et al: Ubiquitination and
deubiquitination in cancer: From mechanisms to novel therapeutic
approaches. Mol Cancer. 23:1482024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dutta R, Guruvaiah P, Reddi KK, Bugide S,
Reddy Bandi DS, Edwards YJK, Singh K and Gupta R: UBE2T promotes
breast cancer tumor growth by suppressing DNA replication stress.
NAR Cancer. 4:zcac0352022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma N, Li Z, Yan J, Liu X, He L, Xie R and
Lu X: Diverse roles of UBE2T in cancer (Review). Oncol Rep.
49:692023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yin H, Wang X, Zhang X, Zeng Y, Xu Q, Wang
W, Zhou F and Zhou Y: UBE2T promotes radiation resistance in
non-small cell lung cancer via inducing epithelial-mesenchymal
transition and the ubiquitination-mediated FOXO1 degradation.
Cancer Lett. 494:121–131. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ho NPY, Leung CON, Wong TL, Lau EYT, Lei
MML, Mok EHK, Leung HW, Tong M, Ng IOL, Yun JP, et al: The
interplay of UBE2T and Mule in regulating Wnt/β-catenin activation
to promote hepatocellular carcinoma progression. Cell Death Dis.
12:1482021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hao P, Kang B, Li Y, Hao W and Ma F: UBE2T
promotes proliferation and regulates PI3K/Akt signaling in renal
cell carcinoma. Mol Med Rep. 20:1212–1220. 2019.PubMed/NCBI
|
|
23
|
Kim JW, Gautam J, Kim JE, Kim JA and Kang
KW: Inhibition of tumor growth and angiogenesis of
tamoxifen-resistant breast cancer cells by ruxolitinib, a selective
JAK2 inhibitor. Oncol Lett. 17:3981–3989. 2019.PubMed/NCBI
|
|
24
|
Bai Y, Wang W, Yin P, Gao J, Na L, Sun Y,
Wang Z, Zhang Z and Zhao C: Ruxolitinib alleviates renal
interstitial fibrosis in UUO Mice. Int J Biol Sci. 16:194–203.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Onozato Y, Kaida A, Harada H and Miura M:
Radiosensitivity of quiescent and proliferating cells grown as
multicellular tumor spheroids. Cancer Sci. 108:704–712. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sakaue-Sawano A, Kurokawa H, Morimura T,
Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi
H, et al: Visualizing spatiotemporal dynamics of multicellular
cell-cycle progression. Cell. 132:487–498. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45((W1)):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Győrffy B: Integrated analysis of public
datasets for the discovery and validation of survival-associated
genes in solid tumors. Innovation (Camb). 5:1006252024.PubMed/NCBI
|
|
29
|
Miyoshi H, Blömer U, Takahashi M, Gage FH
and Verma IM: Development of a self-inactivating lentivirus vector.
J Virol. 72:8150–8157. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kodama S, Podyma-Inoue KΑ, Uchihashi T,
Kurioka K, Takahashi H, Sugauchi A, Takahashi K, Inubushi T, Kogo
M, Tanaka S and Watabe T: Progression of melanoma is suppressed by
targeting all transforming growth factor-β isoforms with an Fc
chimeric receptor. Oncol Rep. 46:1972021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takahashi K, Akatsu Y, Podyma-Inoue KA,
Matsumoto T, Takahashi H, Yoshimatsu Y, Koinuma D, Shirouzu M,
Miyazono K and Watabe T: Targeting all transforming growth factor-β
isoforms with an Fc chimeric receptor impairs tumor growth and
angiogenesis of oral squamous cell cancer. J Biol Chem.
295:12559–12572. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pfaffl MW: Relative quantification.
Real-time PCR and Dorak MT: 1st edition. Taylor & Francis;
London: 2006
|
|
34
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: a
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43((Database issue)): D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu X, Zhong D, Wang X, Luo F, Zheng X,
Feng T, Chen R, Cheng Y, Wang Y and Ma G: Pan-cancer integrated
analysis of ANKRD1 expression, prognostic value, and potential
implications in cancer. Sci Rep. 14:52682024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Harrison M, Zinovkin D and Pranjol MZI:
Endothelin-1 and its role in cancer and potential therapeutic
opportunities. Biomedicines. 12:5112024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ibi H, Takahashi K, Harada H, Watabe T and
Podyma-Inoue KA: Transforming growth factor-β signals promote
progression of squamous cell carcinoma by inducing
epithelial-mesenchymal transition and angiogenesis. Biochem Biophys
Res Commun. 714:1499652024. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sarno F, Goubert D, Logie E, Rutten MGS,
Koncz M, Deben C, Niemarkt AE, Altucci L, Verschure PJ, Kiss A, et
al: Functional validation of the putative oncogenic activity of
PLAU. Biomedicines. 11:1022022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yadav A, Kumar B, Datta J, Teknos TN and
Kumar P: IL-6 promotes head and neck tumor metastasis by inducing
epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling
pathway. Mol Cancer Res. 9:1658–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thuya WL, Cao Y, Ho PC, Wong AL, Wang L,
Zhou J, Nicot C and Goh BC: Insights into IL-6/JAK/STAT3 signaling
in the tumor microenvironment: Implications for cancer therapy.
Cytokine Growth Factor Rev. Jan 17–2025.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gao C, Liu YJ, Yu J, Wang R, Shi JJ, Chen
RY, Yang GJ and Chen J: Unraveling the role of
ubiquitin-conjugating enzyme UBE2T in tumorigenesis: A
comprehensive review. Cells. 4:152024. View Article : Google Scholar
|
|
45
|
Augoff K, Hryniewicz-Jankowska A, Tabola R
and Stach K: MMP9: A tough target for targeted therapy for cancer.
Cancers (Basel). 14:18472022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kumari N, Dwarakanath BS, Das A and Bhatt
AN: Role of interleukin-6 in cancer progression and therapeutic
resistance. Tumour Biol. 37:11553–11572. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cai F, Xu H, Song S, Wang G, Zhang Y, Qian
J and Xu L: Knockdown of ubiquitin-conjugating enzyme E2 T
abolishes the progression of head and neck squamous cell carcinoma
by inhibiting NF-κb signaling and inducing ferroptosis. Curr
Protein Pept Sci. 25:577–585. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yu Z, Jiang X, Qin L, Deng H, Wang J, Ren
W, Li H, Zhao L, Liu H, Yan H, et al: A novel UBE2T inhibitor
suppresses Wnt/β-catenin signaling hyperactivation and gastric
cancer progression by blocking RACK1 ubiquitination. Oncogene.
40:1027–1042. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pu J, Wang B, Zhang D, Wang K, Yang Z, Zhu
P and Song Q: UBE2T mediates SORBS3 ubiquitination to enhance
IL-6/STAT3 signaling and promote lung adenocarcinoma progression. J
Biochem Mol Toxicol. 38:e237432024. View Article : Google Scholar : PubMed/NCBI
|
